High‐dose carboplatin–irinotecan–temozolomide: Treatment option for neuroblastoma resistant to topotecan
Year: 2010
Type: article
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.22855
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: G4961134886
OpenAlex ID: W2099134748